Potential transition-state inhibitors of glyoxalase. I

2009 ◽  
Vol 22 (S9) ◽  
pp. 335-343
Author(s):  
Richard B. Brandt ◽  
Mark E. Brandt ◽  
Michael E. April ◽  
Colin Thomson
Biochemistry ◽  
1999 ◽  
Vol 38 (41) ◽  
pp. 13480-13490 ◽  
Author(s):  
Alexander D. Cameron ◽  
Marianne Ridderström ◽  
Birgit Olin ◽  
Malcolm J. Kavarana ◽  
Donald J. Creighton ◽  
...  

Author(s):  
Kenneth T. Douglas ◽  
Dhanesh I. Gohel ◽  
Iffat N. Nadvi ◽  
A.Joy Quilter ◽  
Andrew P. Seddon

2003 ◽  
Vol 70 ◽  
pp. 213-220 ◽  
Author(s):  
Gerald Koelsch ◽  
Robert T. Turner ◽  
Lin Hong ◽  
Arun K. Ghosh ◽  
Jordan Tang

Mempasin 2, a ϐ-secretase, is the membrane-anchored aspartic protease that initiates the cleavage of amyloid precursor protein leading to the production of ϐ-amyloid and the onset of Alzheimer's disease. Thus memapsin 2 is a major therapeutic target for the development of inhibitor drugs for the disease. Many biochemical tools, such as the specificity and crystal structure, have been established and have led to the design of potent and relatively small transition-state inhibitors. Although developing a clinically viable mempasin 2 inhibitor remains challenging, progress to date renders hope that memapsin 2 inhibitors may ultimately be useful for therapeutic reduction of ϐ-amyloid.


1999 ◽  
Vol 97 (8) ◽  
pp. 967-976 ◽  
Author(s):  
M. Garay Salazar, J. M. Orea Rocha, A.

2013 ◽  
Vol 8 (S 01) ◽  
Author(s):  
S Müller-Krebs ◽  
S Schmidt ◽  
A Erhardt ◽  
PP Nawroth ◽  
V Schwenger
Keyword(s):  

2014 ◽  
Vol 52 (08) ◽  
Author(s):  
M Hollenbach ◽  
A Thonig ◽  
S Pohl ◽  
C Ripoll ◽  
A Zipprich
Keyword(s):  

2015 ◽  
Vol 53 (01) ◽  
Author(s):  
M Hollenbach ◽  
A Thonig ◽  
S Pohl ◽  
C Ripoll ◽  
A Zipprich
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document